Pressure Biosciences (PBIO) Stock Price & Overview
NASDAQ:PBIO
Current stock price
The current stock price of PBIO is 3.39 null. Today PBIO is up by 455.74%. In the past month the price increased by 465%. In the past year, price increased by 202.68%.
PBIO Key Statistics
- Market Cap
- 3.729M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- N/A
- Dividend Yield
- N/A
PBIO Stock Performance
PBIO Stock Chart
PBIO Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to PBIO. When comparing the yearly performance of all stocks, PBIO is one of the better performing stocks in the market, outperforming 99.66% of all stocks.
PBIO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to PBIO. PBIO has a bad profitability rating. Also its financial health evaluation is rather negative.
PBIO Earnings
PBIO Forecast & Estimates
PBIO Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 100.05% | ||
| ROA | -653.69% | ||
| ROE | 0% | ||
| Debt/Equity | 0 |
PBIO Ownership
About PBIO
Company Profile
Pressure BioSciences, Inc is a company focused on the development of a novel technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (35,000 psi and greater) to control bio- molecular interactions. Pressure BioSciences holds US and foreign patents covering multiple applications of PCT in the life sciences field, including in such areas as genomic and proteomic sample preparation, pathogen inactivation, control of enzymes, immunodiagnostics, and protein purification.
Company Info
Pressure Biosciences
14 NORFOLK AVENUE
SOUTH EASTON MA 02375
CEO: Richard T. Schumacher
Phone: 508-230-1828
Pressure Biosciences / PBIO FAQ
Can you describe the business of Pressure Biosciences?
Pressure BioSciences, Inc is a company focused on the development of a novel technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (35,000 psi and greater) to control bio- molecular interactions. Pressure BioSciences holds US and foreign patents covering multiple applications of PCT in the life sciences field, including in such areas as genomic and proteomic sample preparation, pathogen inactivation, control of enzymes, immunodiagnostics, and protein purification.
What is the current price of PBIO stock?
The current stock price of PBIO is 3.39 null. The price increased by 455.74% in the last trading session.
What is the dividend status of Pressure Biosciences?
PBIO does not pay a dividend.
How is the ChartMill rating for Pressure Biosciences?
PBIO has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 1 out of 10.